Llwytho...
Distinguishing Pharmacokinetics of Marketed Nanomedicine Formulations Using a Stable Isotope Tracer Assay
[Image: see text] The pharmacokinetics of nanomedicines are complicated by the unique dispositional characteristics of the drug carrier. Most simplistically, the carrier could be a solubilizing platform that allows administration of a hydrophobic drug. Alternatively, the carrier could be stable and...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | ACS Pharmacol Transl Sci |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American
Chemical Society
2020
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7296544/ https://ncbi.nlm.nih.gov/pubmed/32566919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00011 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|